30th Edition of Oncology Summit | 04-06 December 2025 | Dubai, United Arab Emirates (Hybird)
31st Edition of Oncology Summit | 19-22 February 2026 | Amsterdam, Netherlands
32nd Edition of Oncology Summit | 16-19 April 2026 | London, United Kingdom
Conference logo
Doug Miller, M.D., Director Radiation Oncology at Hackensack Meridian Health Jersey Shore University Medical Center, discusses the benefits of receiving care under the Hackensack Meridian Cancer Care network. More information – https://oncologyandcancerresearch.blogspot.com/
Immunotherapy with the emergence of novel treatments such as checkpoint inhibitors, adoptive T-cell transfer, and cancer vaccines, there has been significant progress in the field of cancer immunotherapy Precision medicine involves tailoring cancer treatment to a patient’s specific genomic profile. Early detection is crucial for effective cancer treatment Researchers are investigating novel biomarkers and diagnostic technologies to improve the early detection of cancer, such as liquid biopsies and advanced imaging techniques. Targeted therapy involves using drugs that target specific molecules or pathways involved in cancer growth and progression. Combination therapy involves using multiple treatments to attack cancer from different angles
More information – https://oncologyandcancerresearch.blogspot.com/
The different types of Brain tumors that occur, and sheds light on the treatment options for malignant and benign tumors.
More information – https://oncologyandcancerresearch.blogspot.com/
Shuanglin Qin, Ph.D., graduated from the School of Pharmaceutical Science and Technology, Tianjin University. Post-doctor of the General Hospital of Chinese People’s Liberation Army. He is work at Hubei University of Science and Technology now. Mainly engaged in the mechanism study and drug development based on natural products. Winners of “ChuTian Scholars Program” in Hubei Province, China. Winners of “Hundred Talent Program” of Hubei University of Science and Technology. He has presided over many projects, including the National Natural Science Foundation of China, the China Postdoctoral Science Foundation, Hubei Science and Technology Program, Young and Middle-aged Talent Project of Hubei Provincial Department of Education, Youth Talent Project of Health Commission of Hubei Province, etc. He is the academic editor of Journal of Oncology, and the member of youth editorial board of Traditional Medicine Research, Life research and Medical Data Mining. He is the reviewer of European Journal of Medicinal Chemistry, Frontiers in Cell and Developmental Biology, etc.
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of all cases. NSCLC can be further classified into several subtypes, including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. The term “non-small cell” is used to distinguish these subtypes from small cell lung cancer, which is a less common but more aggressive type of lung cancer.
Symptoms may include coughing, chest pain, shortness of breath, fatigue, weight loss, and coughing up blood.
Treatment options for NSCLC depend on several factors, including the stage of the cancer, the subtype, and the patient’s overall health. Surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy may all be used alone or in combination to treat NSCLC.
Chemotherapy is a type of cancer treatment that uses drugs to destroy cancer cells. The specific treatment regimen for chemotherapy depends on various factors, including the type of cancer, its stage, the patient’s health condition, and other factors. However, here are some general guidelines for the treatment of chemotherapy:
Administering chemotherapy drugs: The chemotherapy drugs are usually given through an intravenous (IV) line, which is a thin tube inserted into a vein. In some cases, chemotherapy drugs may be given orally, topically, or by injection.
Managing side effects: Chemotherapy can cause various side effects, such as nausea, vomiting, hair loss, fatigue, and increased risk of infection. To manage these side effects, the patient may be given medications, changes in diet or lifestyle, and supportive therapies such as hydration and rest.
Monitoring the patient: During chemotherapy treatment, the patient’s health condition should be monitored regularly. This includes checking blood counts, assessing organ function, and monitoring for signs of infection.
Adjusting the treatment: The chemotherapy treatment may need to be adjusted depending on the patient’s response to the treatment and any side effects that occur. The dosage and frequency of chemotherapy may be changed, or other treatments may be added to manage side effects or improve the effectiveness of the treatment.